Structure Therapeutics (GPCR) Return on Capital Employed [ROCE] (2023 - 2026)
Structure Therapeutics (GPCR) reported Return on Capital Employed [ROCE] of -18.41% for Q2 2026, up 8.97 percentage points from -27.37% a year earlier but down 4.33 percentage points from the prior quarter.
Structure Therapeutics (GPCR) Return on Capital Employed [ROCE] (2023 - 2026) Analysis & Trends
For FY2025, Structure Therapeutics posted Return on Capital Employed [ROCE] of -14.96%, up 9.14 percentage points from FY2024.
- By year, Return on Capital Employed [ROCE] came in at -24.10% in FY2024 (+14.66 pp) and -38.76% in FY2023.
- Five-year quarterly Return on Capital Employed [ROCE] spans a low of -41.78% in Q3 2023 and a high of -14.08% in Q1 2026.
- Year over year, Return on Capital Employed [ROCE] has now increased in each of the last three quarters, with an average year-over-year change of +4.64 percentage points over the last eight quarters.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2024 (a gain of 26.10 percentage points); the low point was Q3 2025 (a drop of 16.61 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -14.08% (Q1 2026), -15.42% (Q4 2025) and -32.29% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 17.83% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 17.92% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.28% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 19.32% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 9.54% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 16.66% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -5.97% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 11.86% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.76% |
| 10 | Structure Therapeutics | 7.49 Bn | 7.49 Bn | - | -18.41% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.41% |
| Mar 31, 2026 | -14.08% |
| Dec 31, 2025 | -15.42% |
| Sep 30, 2025 | -32.29% |
| Jun 30, 2025 | -27.37% |
| Mar 31, 2025 | -21.51% |
| Dec 31, 2024 | -17.93% |
| Sep 30, 2024 | -15.68% |
| Jun 30, 2024 | -18.02% |
| Mar 31, 2024 | -25.81% |
| Dec 31, 2023 | -31.68% |
| Sep 30, 2023 | -41.78% |
| Jun 30, 2023 | -31.91% |
| Mar 31, 2023 | -36.67% |
Structure Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GPCR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "GPCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GPCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();